|
Market Closed -
Nasdaq
04:00:00 25/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 34.83 USD | +0.23% |
|
+0.85% | +13.08% |
| 09-24 | AbbVie Says Health Canada Issues Notice of Compliance for EPKINLY in Follicular Lymphoma | MT |
| 09-24 | Hansa Biopharma brings in two new board members | FW |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 1.41% | 1.54% | 21.09x | 4.97x | 7.5x | 15.07x | 17.05x | 71.94B | ||
| 0.04% | 0.08% | 30.84x | 6.08x | 8.88x | 27.67x | 28.18x | 59.35B | ||
| -.--% | -.--% | 31.46x | 3.3x | 6.7x | 17.4x | 20.86x | 27.16B | ||
| -.--% | -.--% | -74.58x | 37.23x | 14.32x | -78x | -83.4x | 26.54B | ||
| -.--% | -.--% | -15.32x | 1.25x | 5.85x | -7.35x | -5.8x | 24.93B | ||
| -.--% | -.--% | 28.35x | 3.38x | 5.34x | 17.75x | 19.88x | 20.61B | ||
| 0.35% | 0.2% | 43.56x | 10.84x | 15.96x | 32.38x | 34.97x | 15.03B | ||
| -.--% | -.--% | 1013.62x | 16.44x | 35.48x | 612.89x | -229.58x | 14.2B | ||
| -.--% | -.--% | 17.9x | 5.51x | 5.33x | 12.45x | 13.2x | 14.36B | ||
| -.--% | -.--% | -14.29x | 48.98x | 3217.4x | -16.47x | -14.12x | 13.07B | ||
| -.--% | -.--% | -81.62x | 26.41x | 7.42x | -63.61x | -60.67x | 11.86B | ||
| -.--% | 0.01% | -410.34x | 8.34x | 14.94x | 931.9x | -274.89x | 11.03B | ||
| -.--% | -.--% | -18.15x | 23.96x | 18.41x | -19.77x | -17.8x | 9.33B | ||
| -.--% | -.--% | -10.72x | -68.83x | 53.19x | -11.09x | -10.89x | 9.13B | ||
| -.--% | -.--% | 7.96x | 4.41x | 6.81x | 11.05x | 11.42x | 8.06B | ||
| -.--% | -.--% | -6.79x | - | - | -7.03x | -6.51x | 8.47B | ||
| -.--% | -.--% | -29.76x | 7.82x | - | -26.12x | -26.96x | 7.68B | ||
| Average | 0.11% | 0.11% | 31.37x | 8.76x | 228.24x | 85.24x | -34.42x | 20.75B | |
| Weighted average by Cap. | 0.31% | 0.34% | 32.78x | 9.03x | 135.80x | 55.37x | -15.31x |
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
- Sector Genmab A/S
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















